Literature DB >> 7966125

A new class of non-peptidic cholecystokinin-B/gastrin receptor antagonists based on dibenzobicyclo[2.2.2]octane.

S B Kalindjian1, M J Bodkin, I M Buck, D J Dunstone, C M Low, I M McDonald, M J Pether, K I Steel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7966125     DOI： 10.1021/jm00048a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  3 in total

1.  Analysis of variation in L-365,260 competition curves in radioligand binding assays.

Authors:  E A Harper; S P Roberts; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

2.  Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.

Authors:  S P Roberts; E A Harper; G F Watt; V P Gerskowitch; R A Hull; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

3.  Analysis of the behaviour of selected CCKB/gastrin receptor antagonists in radioligand binding assays performed in mouse and rat cerebral cortex.

Authors:  E A Harper; E P Griffin; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.